Selected research
Industry Research
CRO in Clinical Trials Industry Research Report 2026
Market perspective
The global CRO in Clinical Trials market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the CRO in Clinical Trials market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the CRO in Clinical Trials market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the CRO in Clinical Trials market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of CRO in Clinical Trials include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global CRO in Clinical Trials market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to CRO in Clinical Trials.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CRO in Clinical Trials Market by Company
Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
MedPace
Wuxi AppTec
CRO in Clinical Trials Segment by Type
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
CRO in Clinical Trials Segment by End User
Pharmaceutical
Bio-pharm
Others
CRO in Clinical Trials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRO in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO in Clinical Trials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of CRO in Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Phase I Trial
- Phase II Trial
- Phase III Trial
- Phase IV Trial
Applications
- Pharmaceutical
- Bio-pharm
- Others
Companies covered
- Labcorp
- IQVIA
- Parexel
- Syneos Health
- PRA Health Sciences
- PPD
- ICON
- MedPace
- Wuxi AppTec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 CRO in Clinical Trials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Phase I Trial
- 2.2.3 Phase II Trial
- 2.2.4 Phase III Trial
- 2.2.5 Phase IV Trial
- 2.3 CRO in Clinical Trials by End User
- 2.3.1 Market Value Comparison by End User (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Bio-pharm
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 CRO in Clinical Trials Breakdown Data by Type
- 3.1 Global CRO in Clinical Trials Historic Market Size by Type (2021-2026)
- 3.2 Global CRO in Clinical Trials Forecasted Market Size by Type (2027-2032)
4 CRO in Clinical Trials Breakdown Data by End User
- 4.1 Global CRO in Clinical Trials Historic Market Size by End User (2021-2026)
- 4.2 Global CRO in Clinical Trials Forecasted Market Size by End User (2027-2032)
5 Global Growth Trends
- 5.1 Global CRO in Clinical Trials Market Perspective (2021-2032)
- 5.2 Global CRO in Clinical Trials Growth Trends by Region
- 5.2.1 Global CRO in Clinical Trials Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 CRO in Clinical Trials Historic Market Size by Region (2021-2026)
- 5.2.3 CRO in Clinical Trials Forecasted Market Size by Region (2027-2032)
- 5.3 CRO in Clinical Trials Market Dynamics
- 5.3.1 CRO in Clinical Trials Industry Trends
- 5.3.2 CRO in Clinical Trials Market Drivers
- 5.3.3 CRO in Clinical Trials Market Challenges
- 5.3.4 CRO in Clinical Trials Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top CRO in Clinical Trials Players by Revenue
- 6.1.1 Global Top CRO in Clinical Trials Players by Revenue (2021-2026)
- 6.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2021-2026)
- 6.2 Global CRO in Clinical Trials Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of CRO in Clinical Trials Head Office and Area Served
- 6.4 Global CRO in Clinical Trials Players, Product Type & Application
- 6.5 Global CRO in Clinical Trials Manufacturers Established Date
- 6.6 Global CRO in Clinical Trials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America CRO in Clinical Trials Market Size (2021-2032)
- 7.2 North America CRO in Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America CRO in Clinical Trials Market Size by Country (2021-2026)
- 7.4 North America CRO in Clinical Trials Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe CRO in Clinical Trials Market Size (2021-2032)
- 8.2 Europe CRO in Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe CRO in Clinical Trials Market Size by Country (2021-2026)
- 8.4 Europe CRO in Clinical Trials Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific CRO in Clinical Trials Market Size (2021-2032)
- 9.2 Asia-Pacific CRO in Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific CRO in Clinical Trials Market Size by Country (2021-2026)
- 9.4 Asia-Pacific CRO in Clinical Trials Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America CRO in Clinical Trials Market Size (2021-2032)
- 10.2 South America CRO in Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America CRO in Clinical Trials Market Size by Country (2021-2026)
- 10.4 South America CRO in Clinical Trials Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa CRO in Clinical Trials Market Size (2021-2032)
- 11.2 Middle East & Africa CRO in Clinical Trials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa CRO in Clinical Trials Market Size by Country (2021-2026)
- 11.4 Middle East & Africa CRO in Clinical Trials Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Labcorp
- 12.1.1 Labcorp Company Information
- 12.1.2 Labcorp Business Overview
- 12.1.3 Labcorp Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.1.4 Labcorp CRO in Clinical Trials Product Portfolio
- 12.1.5 Labcorp Recent Developments
- 12.2 IQVIA
- 12.2.1 IQVIA Company Information
- 12.2.2 IQVIA Business Overview
- 12.2.3 IQVIA Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.2.4 IQVIA CRO in Clinical Trials Product Portfolio
- 12.2.5 IQVIA Recent Developments
- 12.3 Parexel
- 12.3.1 Parexel Company Information
- 12.3.2 Parexel Business Overview
- 12.3.3 Parexel Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.3.4 Parexel CRO in Clinical Trials Product Portfolio
- 12.3.5 Parexel Recent Developments
- 12.4 Syneos Health
- 12.4.1 Syneos Health Company Information
- 12.4.2 Syneos Health Business Overview
- 12.4.3 Syneos Health Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.4.4 Syneos Health CRO in Clinical Trials Product Portfolio
- 12.4.5 Syneos Health Recent Developments
- 12.5 PRA Health Sciences
- 12.5.1 PRA Health Sciences Company Information
- 12.5.2 PRA Health Sciences Business Overview
- 12.5.3 PRA Health Sciences Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.5.4 PRA Health Sciences CRO in Clinical Trials Product Portfolio
- 12.5.5 PRA Health Sciences Recent Developments
- 12.6 PPD
- 12.6.1 PPD Company Information
- 12.6.2 PPD Business Overview
- 12.6.3 PPD Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.6.4 PPD CRO in Clinical Trials Product Portfolio
- 12.6.5 PPD Recent Developments
- 12.7 ICON
- 12.7.1 ICON Company Information
- 12.7.2 ICON Business Overview
- 12.7.3 ICON Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.7.4 ICON CRO in Clinical Trials Product Portfolio
- 12.7.5 ICON Recent Developments
- 12.8 MedPace
- 12.8.1 MedPace Company Information
- 12.8.2 MedPace Business Overview
- 12.8.3 MedPace Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.8.4 MedPace CRO in Clinical Trials Product Portfolio
- 12.8.5 MedPace Recent Developments
- 12.9 Wuxi AppTec
- 12.9.1 Wuxi AppTec Company Information
- 12.9.2 Wuxi AppTec Business Overview
- 12.9.3 Wuxi AppTec Revenue in CRO in Clinical Trials Business (2021-2026)
- 12.9.4 Wuxi AppTec CRO in Clinical Trials Product Portfolio
- 12.9.5 Wuxi AppTec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst